Global Cancer Drugs Market, 2016 – 2022
Global cancer drugs market is expected to reach USD 161.30 billion by end of 2021, growing at a CAGR of around 7.4
Global cancer drugs market is expected to reach USD 161.30 billion by end of 2021, growing at a CAGR of around 7.4
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Published By: Zion <strong>Market</strong> Research<br />
<strong>Global</strong> <strong>Cancer</strong> <strong>Drugs</strong> <strong>Market</strong> booming at USD<br />
161.30 Million by 2021<br />
Contact Us:<br />
4283, Express Lane, Suite 634-143,<br />
Sarasota, Florida 34249, United States<br />
Tel: +1-386-310-3803 GMT<br />
Tel: +49-322 210 92714<br />
USA/Canada Toll Free No.1-855-465-4651<br />
sales@zionmarketresearch.com
<strong>Cancer</strong> <strong>Drugs</strong> <strong>Market</strong><br />
Zion <strong>Market</strong> Research has published a new report titled “<strong>Cancer</strong> <strong>Drugs</strong> <strong>Market</strong> by Therapy<br />
(Immunotherapy, Targeted Therapy, Chemotherapy, Hormone Therapy and Others)<br />
for Breast <strong>Cancer</strong>, Blood <strong>Cancer</strong>, Gastrointestinal <strong>Cancer</strong>, Prostate <strong>Cancer</strong>, Skin<br />
<strong>Cancer</strong>, Lung <strong>Cancer</strong> and Other <strong>Cancer</strong>: <strong>Global</strong> Industry Perspective, Comprehensive<br />
Analysis and Forecast, 2015 <strong>–</strong> 2021”. According to the report, global cancer drugs<br />
market was valued at approximately USD 112.90 billion in 2015 and is expected to generate<br />
revenue of around USD 161.30 billion by end of 2021, growing at a CAGR of around 7.4%<br />
between <strong>2016</strong> and 2021.<br />
<strong>Cancer</strong> is defined as a disease which occurs as a result of changes in a group of normal cells<br />
within the body which leads to uncontrolled growth resulting in the formation of lump called a<br />
tumor; (except for cancer of the blood). If left untreated, tumors can grow and spread into the<br />
surrounding normal tissue, or to other parts of the body via lymphatic systems and the<br />
bloodstream, and can in turn severely impact the functioning of the digestive, nervous and<br />
circulatory systems.<br />
Request Free Sample Research Report @<br />
https://www.zionmarketresearch.com/sample/cancer-drugs-market
<strong>Cancer</strong> <strong>Drugs</strong> <strong>Market</strong><br />
<strong>Global</strong> cancer drugs market is primarily driven by growing incidences of target disease such as<br />
lung cancer, breast cancer, cervical cancer, etc. across the globe. Other major driving factors<br />
are increasing research and development on biological and targeted drug therapies for the<br />
treatment of cancer coupled along with the expiration of patents. However, the high price of<br />
drug development and stringent regulatory policies coupled along with the possibility of failure<br />
are the major restraints that may limit the growth of the market. Nonetheless increasing focus<br />
on personalized medicine coupled along with huge investment in anti-cancer drugs research<br />
across the globe is likely to disclose the new avenues for cancer drugs market in the near<br />
future.<br />
The cancer drugs market is segmented on the basis of the different therapeutic segment<br />
including immunotherapy, targeted therapy, chemotherapy, hormone therapy and others.<br />
Immunotherapy segment is expected to grow at fastest rate in the global market over the<br />
forecast period.<br />
Inquire more about this report @ https://www.zionmarketresearch.com/inquiry/cancerdrugs-market<br />
Breast cancer, blood cancer, gastrointestinal cancer, prostate cancer, skin cancer, lung cancer<br />
and others are the key cancer types of the global cancer drugs market. The blood cancer<br />
segment dominated the market in terms of revenue.
<strong>Cancer</strong> <strong>Drugs</strong> <strong>Market</strong><br />
North America, Europe, Asia-Pacific, Latin America and the Middle East & Africa are key regional<br />
segments of global cancer drugs market. North America is anticipated to remain the leading<br />
region over the forecast period in 2015. Demand for cancer drugs was highest in North America<br />
especially in the U.S. Hence, Asia Pacific is expected to be the moderate growing region in<br />
cancer drugs market during the forecast period. Moreover, the Middle East and Africa and Latin<br />
America are also expected to show moderate growth for this market in the years to come.<br />
Some of the key players in cancer drugs market include Bayer, GlaxoSmithKline, Novartis,<br />
Sanofi and Pfizer, Amgen, Merck, Bristol-Myers Squibb, Celgene Corporation, Ariad<br />
Pharmaceuticals, Eli Lilly, Hoffmann-La Roche Ltd, Boehringer Ingelheim GmbH, Johnson and<br />
Johnson and Teva Pharmaceuticals among others.<br />
Browse the full report at https://www.zionmarketresearch.com/report/cancer-drugs-market
<strong>Cancer</strong> <strong>Drugs</strong> <strong>Market</strong><br />
Zion <strong>Market</strong> Research<br />
Address: 4283, Express Lane, Suite 634-143, Sarasota, Florida 34249, United States<br />
Tel: +1-386-310-3803 GMT +49-322 210 92714<br />
Tel: +1-855-465-4651 (US/CAN TOLL FREE)<br />
Email: sales@zionmarketresearch.com Web: www.zionmarketresearch.com
Change language